Treatment Innovations
-
Facebook
-
Twitter
-
Linkedin
Innovations in cancer treatment are transforming patient care by introducing more precise, effective, and less invasive therapies. Immunotherapy, including checkpoint inhibitors and CAR-T cell therapy, has revolutionized cancer care by harnessing the immune system to target and destroy cancer cells.

RNA molecule identified as possible driver of gastric cancer
Researchers at Case Western Reserve University have discovered molecules that present the potential to drive the development of gastric cancer—among the world’s deadliest forms of the disease.

Scientists find causes of major types of cancer
Many of the most common cancers in the United States are influenced by human choices.

Scientists find root cause of deadly ovarian cancer
Researchers have discovered the likely origin of a deadly form of ovarian cancer, offering new hope for early detection and better treatments.

This plant compound may help stop deadly brain cancer
Scientists at UCLA have discovered a potential new way to treat glioblastoma, the most aggressive type of brain cancer.

Chinese scientists turn tumours into ‘pork’ in radical cancer treatment
Scientists have turned the same immune response that rejects organ transplants to their advantage – to target cancer.

Cancer Vaccines Are Suddenly Looking Extremely Promising
With the help of mRNA technology proven effective during the COVID pandemic, researchers are now closer than ever to creating viable cancer vaccines.

Gold nanoparticles take cancer treatment to the next level with imaging tech
Imagine if doctors could see exactly where cancer medicine goes inside your body, how long it stays, and whether it reaches the tumor effectively.

Immunotherapy may boost KRAS-targeted therapy in pancreatic cancer
Adding immunotherapy to a new type of inhibitor that targets multiple forms of the cancer-causing gene mutation KRAS kept pancreatic cancer at bay in preclinical models for significantly longer than the same targeted therapy by itself, according to researchers from the Perelman School of Medicine at the University of Pennsylvania and Penn Medicine’s Abramson Cancer Center.

Pittsburgh hospital using new cancer-fighting technology, machine 1 of 15 in entire country
The Elekta Unity MR-LINAC system, used at Allegheny General Hospital, combines MRI imaging with radiation therapy to target cancerous cells.

Innovative CT scan technique could improve prognosis and treatments for head and neck cancers
Cancers occurring in the mouth, nose, and throat are on the rise in the U.S., especially in younger people. About 60,000 new cases are diagnosed every year, with one in five cases occurring in people younger than 55, according to the American Cancer Society. A new study provides insights that may eventually help oncologists better predict how the disease will respond to certain therapies, leading to improved survival outcomes for patients.

New mRNA vaccine may help pancreatic cancer patients live longer
A new type of mRNA vaccine, added to standard cancer treatment, could help some patients with pancreatic cancer live longer. A small study at Memorial Sloan Kettering Cancer Center tested this approach and found promising results.

New technique to measure circulating tumor DNA in metastatic cancer may improve surveillance and outcomes
In metastatic cancer surveillance, monitoring the actual concentrations of circulating tumor DNA (ctDNA) may be critical. Researchers showed that absolute ctDNA concentration thresholds can be defined to rule out or predict impending cancer progression.

Novel Drug Shrinks 73% of HER2-Mutant Lung Cancers
All were partial responses to antibody-drug conjugate in Chinese trial

Pancreatic cancer RNA vaccine shows durable T cell immunity
Memorial Sloan Kettering Cancer Center researchers have found RNA neoantigen vaccines that generate long-lived, functional CD8+ T cells in patients with pancreatic ductal adenocarcinoma (PDAC), potentially delaying disease recurrence.

Rapid Gene Test Aids Brain Cancer Surgery
WEDNESDAY, Feb. 26, 2025 (HealthDay News) — A rapid experimental genetic test can help guide the hands of surgeons as they delicately remove tumors from patients with brain cancer, new research suggests.

Researchers advance non-invasive cancer detection methods
Researchers at Vilnius University have developed an effective approach to liquid biopsy that contributes to the field of non-invasive cancer detection methods, with significant implications for personalized medicine.

Study finds more effective treatment for head and neck cancer
A recent study explored a new way to treat certain patients with head and neck cancer. The researchers tested whether combining radiation therapy with a drug called cetuximab could improve patient outcomes compared to radiation therapy alone.

Study indicates that exercise can help colon cancer survivors live as long as matched individuals
Physical activity may help colon cancer survivors achieve long-term survival rates similar to those of people in the general population, according to a study published in Cancer.

Tardigrade proteins show promise in cancer care
Patients undergoing radiation therapy experience debilitating side effects because of toxicity arising from radiation-induced DNA strand breaks in normal peritumoral cells.

6 Pain Relief Tips for Men With Advanced Prostate Cancer
Not all men with advanced prostate cancer experience pain, but many will, particularly if the cancer has spread to the bones.

Telix kidney cancer imaging agent granted FDA priority review
Telix today announces that the United States (U.S.) Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for its breakthrough investigational kidney cancer PET[1] imaging agent TLX250-CDx (Zircaix®[2], 89Zr-DFO-girentuximab), granted a Priority Review and provided a PDUFA[3] date of 27 August 2025, paving the way for a U.S. commercial launch in 2025.

A protein from tiny tardigrades may help cancer patients tolerate radiation therapy
About 60% of all cancer patients in the United States receive radiation therapy as part of their treatment. However, this radiation can have severe side effects that often end up being too difficult for patients to tolerate.

Widely used diabetes drug could fight cancer, study finds
Metformin is widely used to manage type 2 diabetes, but new research suggests it may also help the immune system fight cancer. A study from the University of Helsinki, published in the Journal for ImmunoTherapy of Cancer, has uncovered how metformin can boost immune cells, making them better at recognizing and attacking cancer cells.

Allegheny Health Network using new robotic tool to diagnose lung cancer
As technology advances in the fight against cancer, Allegheny Health Network is using a new robotic tool to diagnose lung cancer.